Results 251 to 260 of about 499,883 (421)

Comparison of Low‐Gluten Diets Rich in Oats or Rice—A 6‐Week Randomized Clinical Trial With Metabolically Challenged Volunteers

open access: yesMolecular Nutrition &Food Research, EarlyView.
The aim of this study is to compare oats and rice as the main cereal source of a low‐gluten diet followed by metabolically challenged volunteers. The participants consumed four portions of either oat or rice products daily for 6 weeks and avoided glutinous cereals.
Enni Mannila   +9 more
wiley   +1 more source

Association of the TNFRSF1B-rs1061622 variant with nonresponse to infliximab in ulcerative colitis. [PDF]

open access: yesSci Rep
Tessier L   +9 more
europepmc   +1 more source

Epidemiology and the cost burden of hospitalized pediatric‐onset inflammatory bowel disease in China: A national database study

open access: yesPediatric Investigation, EarlyView.
This study provides insights into the clinical characteristics and cost burden of pediatric‐onset inflammatory bowel disease (PIBD) and very early onset IBD (VEO‐IBD) in China. Hospitalizations for PIBD, particularly Crohn's disease, are increasing. Guidelines and health insurance policies can help mitigate the cost burden.
Xiaolu Nie   +11 more
wiley   +1 more source

Signifiance of autoimmune reactions to pancreatic juice in Crohn´s disease [PDF]

open access: yes, 1988
Goebell, Harald   +5 more
core   +1 more source

Mirikizumab pharmacokinetics and exposure–response in pediatric patients with moderate‐to‐severe ulcerative colitis

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 474-485, March 2025.
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani   +5 more
wiley   +1 more source

Radiomics prediction of surgery in ulcerative colitis refractory to medical treatment. [PDF]

open access: yesTech Coloproctol
Sakamoto K   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy